NHS National Framework for Transition products commencing 1 May 2024
Estimated value
£7.6m
Awarded value
£7.6m
Suppliers
1
Lots
1
Published
24 Apr 2024
Description
Project title: NHS National Framework for Transition products commencing 1 May 2024 Offer reference number: CM/TNS/05/2024 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/05/2024/01 - Dimethyl fumarate, Teriflunomide, Trabectedin Lot 1 NWLN: 01/05/2024 to 31/01/2025 (9 months) Lot 2 CESW: 01/05/2024 to 30/09/2025 (17 months) Lot 3 LSNE: 01/05/2024 to 30/09/2025 (17 months) CM/TNS/05/2024/02 - Apixaban, Sapropterin Lot 1 DNW+DNE+DCE 01/05/2024 to 30/09/2025 (17 months) Lot 2 DLS+DLN+DSW 01/05/2024 to 30/09/2025 (17 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Scope
- Reference
- CF-2305300D0O000000rwimUAA
- Total value
- £7,559,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 30 Apr 2024 to 29 Sept 2025
- CPV classifications
- 33600000
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 18 Mar 2024, 1:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£7.6m
Award date
15 Apr 2024
Contract start
30 Apr 2024
Contract end
29 Sept 2025